Ara
Toplam kayıt 81, listelenen: 41-50
Commentary: Peripartum Cardiomyopathy in Intensive Care Unit: an Update
(Frontiers Media Sa, 2016)
We read with interest the article recently published by Dinic et al. entitled “Peripartum Cardiomyopathy in Intensive Care Unit: An Update” (1). However, we have some concerns about the article.
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
(Wiley, 2016)
What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ...
Right Heart Thrombi Treatment
(Elsevier Science Inc, 2017)
Management of prosthetic valve thrombosis: what is the best dosage and administration route of thrombolytics
(Lippincott Williams & Wilkins, 2015)
Management Dilemma in Acute Prosthetic Valve Thrombosis: Surgery or Thrombolysis?
(Wiley-Blackwell, 2015)
Creatine supplementation on cardiac autonomic functions
(Wiley, 2017)
Peripartum cardiomyopathy in the ED
(W B Saunders Co-Elsevier Inc, 2015)
B-type natriuretic peptide in infective endocarditis
(Elsevier Sci Ltd, 2015)
Bridging anticoagulation in patients with mechanical heart valves
(Elsevier Ireland Ltd, 2017)
Rationale, design and methodology of the RAMSES Study: ReAl-life Multicenter Survey Evaluating Stroke Prevention Strategies
(Turkish Soc Cardiology, 2016)
Objective: Atrial fibrillation is the most common arrhythmia and is associated with a five-fold increased risk of thromboembolic events. Vitamin K antagonists (VKAs) have been the mainstay of oral anticoagulant prophylaxis ...